
Kardigan Inc
KARDHealthcare|Biotechnology|USA
$24.55
+0.18 (+0.76%)
Analyst Estimates
annual
{
"date": [],
"revenue_estimate": [],
"net_income_estimate": [],
"ebit_estimate": [],
"ebitda_estimate": [],
"per_share_eps_estimate": [],
"eps_nri_estimate": [],
"dividend_estimate": [],
"operating_cash_flow_per_share_estimate": [],
"book_value_per_share_estimate": [],
"pretax_income_estimate": [],
"roa_estimate": [],
"roe_estimate": [],
"gross_margin_estimate": [],
"pettm_estimate": [],
"operating_cash_flow_estimate": [],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "0.00",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": null,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}
quarterly
{
"date": [],
"revenue_estimate": [],
"net_income_estimate": [],
"ebit_estimate": [],
"ebitda_estimate": [],
"per_share_eps_estimate": [],
"eps_nri_estimate": [],
"dividend_estimate": [],
"operating_cash_flow_per_share_estimate": [],
"book_value_per_share_estimate": [],
"pretax_income_estimate": [],
"roa_estimate": [],
"roe_estimate": [],
"gross_margin_estimate": [],
"pettm_estimate": [],
"operating_cash_flow_estimate": [],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "0.00",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": null,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}